Recruiting PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT03613545

Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Efficacy and Safety of Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Sponsor: Guangzhou First People's Hospital

Conditions Fecal Microbiota Transplantation Irritable Bowel Syndrome

Interventions Infusion of sham fecal microbiota transplantation probiotics, antibiotics or antidepressants

Updated 6 times since 2018 Last updated: Aug 1, 2021 Started: Aug 10, 2018 Primary completion: Dec 31, 2028 Completion: Dec 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Fecal Microbiota Transplantation and Irritable Bowel Syndrome and is currently actively recruiting participants. Guangzhou First People's Hospital leads this study, which shows 6 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Sep 2021 — Jul 2024 [monthly]

Recruiting PHASE2_PHASE3
Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE2_PHASE3
Dec 2018 — Jan 2021 [monthly]

Recruiting PHASE2_PHASE3

▶ Show 1 earlier version

Sep 2018 — Dec 2018 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Aug 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangzhou First People's Hospital

Data source: Guangzhou First People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China